Emmert Mark A, who is Director at Expeditors International of Washington, sold 4,747 shares at $44.09 on Nov. 10, 2014. Following this transaction, the Director owned 17,435 shares meaning that the stake was reduced by 21.4% with the 4,747-share transaction.

The shares most recently traded at $44.26, up $0.17, or 0.38% since the insider transaction. Historical insider transactions for Expeditors International of Washington go as follows:

4-Week # shares sold: 6,747

12-Week # shares sold: 6,747

24-Week # shares sold: 86,747

The average volume for Expeditors International of Washington has been 1.3 million shares per day over the past 30 days. Expeditors International of Washington has a market cap of $8.5 billion and is part of the services sector and transportation industry. Shares are up 0.11% year-to-date as of the close of trading on Monday.

Expeditors International of Washington, Inc. provides logistics services. The stock currently has a dividend yield of 1.45%. The company has a P/E ratio of 24.6. Currently, there are 5 analysts who rate Expeditors International of Washington a buy, 2 analysts rate it a sell, and 5 rate it a hold.

Brinker Scott M, who is EVP - Chief Investment Officer at Health Care REIT, sold 4,286 shares at $70.84 on Nov. 10, 2014. Following this transaction, the EVP - Chief Investment Officer owned 48,965 shares meaning that the stake was reduced by 8.05% with the 4,286-share transaction.

The shares most recently traded at $70.85, up $0.01, or 0.01% since the insider transaction. Historical insider transactions for Health Care REIT go as follows:

4-Week # shares bought: 2,400

4-Week # shares sold: 1,325

12-Week # shares bought: 2,400

12-Week # shares sold: 4,825

24-Week # shares bought: 2,400

24-Week # shares sold: 14,241

The average volume for Health Care REIT has been 2.4 million shares per day over the past 30 days. Health Care REIT has a market cap of $23.1 billion and is part of the financial sector and real estate industry. Shares are up 32.8% year-to-date as of the close of trading on Monday.

Health Care REIT, Inc. is an independent equity real estate investment trust. The firm engages in acquiring, planning, developing, managing, repositioning and monetizing of real estate assets. It primarily invests in the real estate markets of the United States. The stock currently has a dividend yield of 4.5%. The company has a P/E ratio of 78.5. Currently, there are 6 analysts who rate Health Care REIT a buy, 2 analysts rate it a sell, and 6 rate it a hold.

TheStreet Quant Ratings rates Health Care REIT as a buy. The company's strengths can be seen in multiple areas, such as its increase in stock price during the past year, compelling growth in net income, revenue growth, reasonable valuation levels and good cash flow from operations. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full Health Care REIT Ratings Report from TheStreet Quant Ratings now.

Tarkoff Robert M, who is Director at Advent Software, sold 2,500 shares at $34.85 on Nov. 10, 2014. Following this transaction, the Director owned 2,534 shares meaning that the stake was reduced by 49.66% with the 2,500-share transaction.

The shares most recently traded at $33.43, down $1.42, or 4.26% since the insider transaction. Historical insider transactions for Advent Software go as follows:

4-Week # shares sold: 3,000

12-Week # shares sold: 3,000

24-Week # shares sold: 5,718

The average volume for Advent Software has been 374,200 shares per day over the past 30 days. Advent Software has a market cap of $1.7 billion and is part of the technology sector and computer software & services industry. Shares are down 5.58% year-to-date as of the close of trading on Monday.

Advent Software, Inc. provides software products and services for automating and integrating data and work flows across the investment management organization, as well as between the investment management organization and external parties worldwide. The stock currently has a dividend yield of 1.58%. The company has a P/E ratio of 37.9. Currently, there are 2 analysts who rate Advent Software a buy, no analysts rate it a sell, and 2 rate it a hold.

TheStreet Quant Ratings rates Advent Software as a hold. The company's strengths can be seen in multiple areas, such as its compelling growth in net income, revenue growth and good cash flow from operations. However, as a counter to these strengths, we find that the stock has experienced relatively poor performance when compared with the S&P 500 during the past year. Get the full Advent Software Ratings Report from TheStreet Quant Ratings now.